Journals / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 3

Review of Novel Coronavirus Disease (COVID-19) in India on Available Database

Pages
284–288
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We aimed collection and compilation of scattered informationabout COVID-19 in India and so that this could be used in a suitable manner to combat the disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Novel coronavirus also known as severe acute respiratory syndrome human coronavirus 2 (SARS-CoV-2) was emergedfrom Wuhan, China and have taken catastrophic form globally.
📊
Key Findings & Data:Bats were considered as its primary host but COVID-19 disease became pandemic viahuman to human transmission by droplet nuclei.
💡
Conclusion & Impact:We aimed collection and compilation of scattered informationabout COVID-19 in India and so that this could be used in a suitable manner to combat the disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Novel coronavirus also known as severe acute respiratory syndrome human coronavirus 2 (SARS-CoV-2) was emergedfrom Wuhan, China and have taken catastrophic form globally. India being a dense populated country is also in second stage of virus transmission. Bats were considered as its primary host but COVID-19 disease became pandemic viahuman to human transmission by droplet nuclei. The incubation period ranges upto 14 days and main symptoms ofdisease were noticed as atypical pneumonia, fever, difficult breathing, decreased SPO2 level and ultimately death dueto respiratory failure depending upon immune status of the patients. India has witnessed 229 deaths so far while morethan 6500 cases have been confirmed for COVID-19. Presently India has 21days complete lockdown and taken all immediate preventive measures for control of the disease. We aimed collection and compilation of scattered informationabout COVID-19 in India and so that this could be used in a suitable manner to combat the disease.

🔖

Cite This Article

YADAV, D., YADAV, R. (2022). Review of Novel Coronavirus Disease (COVID-19) in India on Available Database. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 3, 284–288. https://ajindex.com/articles/508668

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Available online at https://www,theguardian.com/ world/2020/mar/13/first-covid-19-case-happened-in-november-china-government-records-show-report 2. Available online at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen 3. Available online at https://www.aljazeera.com/news/2020/01/ timeline-china-coronavirus-spread-200126061554884.html 4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 2020
  2. 497–506. 5. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, Nicholls J, Yee WKS, Yan WW, Cheung MT, Cheng VCC. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003
  3. 1319–25. 6. Centers for Disease Control and Prevention (CDC). Situation summary. Available online at: https://www.cdc.gov/ coronavirus/2019-ncov/index.html 7. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, and Di Napoli R. Features evaluation and treatment coronavirus (COVID-19). StatPearls 2020
  4. Available from: https://www.ncbi.nlm.nih. gov/books/NBK554776/ 8. Hui DS, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan China. Int J Inf Dis 2020
  5. Veljkovic V, Vergara-Alert J, Segalés J, and Paessler S. Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019nCoV: prediction of potential receptor natural reservoir tropism and therapeutic/ vaccine target. F1000 Res 2020
  6. Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, Lane HC, Memish Z, Oh MD, Schuchat A, Ungchusak K. COVID-19: towards controlling of a pandemic. Lancet 2020
  7. 1015–8. 11. Available online at https://who.sprinklr.com/ 12. Mali SN, Pratapb AP, Thorat BR. The Rise of New Coronavirus Infection-(COVID-19): A Recent Update. EJMO 2020
  8. 35–41. 13. Sahin AR, Erdogan A, Agaoglu PM, Dineri Y, Cakirci AY, Senel ME, Okyay RA, Tasdogan AM. Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. EJMO 2020
  9. 1– 7. 14. Available online at https://www.covid19india.org/ 15. Available online at https://weather.com/en-in/india/news/ news/2020-02-14-kerala-defeats-coronavirus-indias-threecovid-19-patients-successfully 16. Available online at https://www.indiatoday.in/india/story/ c